Advertisement

Topics

Clinical hold lifted for Cellectis' early-stage blood cancer drug

04:55 EST 8 Nov 2017 | SmartBrief

The FDA informed Cellectis that the agency removed the clinical hold on its Phase I trial for its chimeric antigen receptor T -More

Original Article: Clinical hold lifted for Cellectis' early-stage blood cancer drug

NEXT ARTICLE

More From BioPortfolio on "Clinical hold lifted for Cellectis' early-stage blood cancer drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...